BiotechTube
Home/Takara Bio/Koichi Nakao
KN

Koichi Nakao

President and Representative Director

Takara Bio

Therapeutic Areas

OncologyRegenerative Medicine

Takara Bio Pipeline

DrugIndicationPhase
TBI-1501Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase I/II
TBI-1401Glioma (Malignant Brain Tumor)Phase I/II
Regenerative Medicine ProgramsCartilage / OsteoarthritisPreclinical / Early Clinical
rAAV-based Gene Therapy ProgramsUndisclosed Rare DiseasesDiscovery / Preclinical

Leadership Team at Takara Bio

KM
Kazuhisa Matsunaga
Director, Senior Managing Executive Officer
LK
Larry K. Brown
President, Takara Bio USA, Inc.
View full Takara Bio profile